Saturday, July 11, 2026

pharma · Not applicable (submitted trial is a bioequivalence in healthy subjects)

SciencePharma

Sciencepharma Sp. z is a pharma organization headquartered in EU. Primary therapeutic focus areas include Not applicable (submitted trial is a bioequivalence in healthy subjects). NovaPharmaNews links 1 clinical program(

Warszawa, EU HQ
2004 Founded
99 Employees
EMA registrant Type
Company details
Status
Public
HQ
Warszawa, EU
Founded
2004
Employees
99
Programs
1
Drugs
3
Patents
0

Quick answer

Sciencepharma Sp. z is a pharma organization headquartered in EU. Primary therapeutic focus areas include Not applicable (submitted trial is a bioequivalence in healthy subjects). NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (1).

Company snapshot

We are a Polish private company operating at the pharmaceutical market since 2004. We offer consultancy services in the field of pharmaceutical projects potential evaluation, related to the development of medicinal products, medical devices and dietary supplements. We specialize in multidisciplinary services of Regulatory Affairs , including pre – authorization, authorization and post – authorizat

  • 1 active pipeline program(s) linked via ClinicalTrials.gov.
  • 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for SciencePharma. Not investment advice.

Lead pipeline drugs

Active clinical programs

  • SPh/01/2024 Not applicable (submitted trial is a bioequivalence in healthy subjects)
    Phase 1
Momentum signals

Momentum

Proprietary activity score for SciencePharma.

0 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 0 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d
Competitive landscape
Recent activity

Recent activity

Latest pipeline, patent, and corporate events for SciencePharma.

  1. Clinical update

    SPh/01/2024 — Phase 1

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is SciencePharma?

    Sciencepharma Sp. z is a pharma organization headquartered in EU. Primary therapeutic focus areas include Not applicable (submitted trial is a bioequivalence in healthy subjects). NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity

  • Is SciencePharma publicly traded?

    SciencePharma appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

  • What drugs does SciencePharma develop or market?

    We link 3 drug profile(s) where SciencePharma is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/sciencepharma-sp-z-o-o#company-drugs.

  • What are the latest developments for SciencePharma?

    In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

  • What therapeutic areas does SciencePharma focus on?

    SciencePharma focuses on Not applicable (submitted trial is a bioequivalence in healthy subjects) based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Others
2